Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis”
Clinical and Molecular Hepatology · 09.11.2026
DOI: 10.3350/cmh.2026.0282 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 09.11.2026. Verfasst von Shi-Jie Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Children's Medical Center, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
- Pancreatitis Treatment Centre, The Affiliated Hospital of Guizhou Medical University, Guizhou Medical University, Guizhou, China. gaoguiying@gmc.edu.cn.
Zitieren
APA
Zhang, S. J., & Gao, G. (2026). Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0282
Vancouver
Zhang SJ, Gao G. Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0282
BibTeX
@article{Zhang2026,
author = {Zhang, Shi-Jie and Gao, Guiying},
title = {Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis”},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0282}
}
EUVIMED